Telelytics was a four-person seed-stage tech startup, seeking to validate their business model for potential investment. The average deal size was roughly $50k ARR, targeting busy doctors and medical practices in the SF Bay Area.
Before the pandemic, the Bay Area medical community viewed remote care with heavy skepticism. The prevailing sentiment among doctors was: "We cannot practice medicine properly if it is remote."
Even more challenging, Telelytics had no external funding, salary, or budget, and likewise no marketing and sales enablement.
Furthermore, cold-calls answer rates were the lowest Angel experienced in his career.
Since cold-calling medical practices failed, Angel pivoted strategy and drove in-person to medical offices to physically knock on doors, buy the medical office lunch, and learn what enablement collateral and features could help the deal. Angel put aside his
Angel feasibility tested seed-stage startup Telelytics in the Bay Area medical practice market. This provided valuable product and marketing feedback, helpful for our investor's acquisition of the technology.